MAGEA12 anticorps (AA 121-210) (Cy3)
Aperçu rapide pour MAGEA12 anticorps (AA 121-210) (Cy3) (ABIN721303)
Antigène
Voir toutes MAGEA12 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 121-210
-
Réactivité croisée
- Humain
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human MAGEA12
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- MAGEA12 (Melanoma Antigen Family A, 12 (MAGEA12))
-
Autre désignation
- MAGEA12
-
Sujet
-
Synonyms: Cancer/testis antigen 1.12, Cancer/testis antigen family 1 member 12, CT1.12, MAGAC_HUMAN, MAGE 12 antigen, MAGE-12 antigen, MAGE12, MAGE12 antigen, MAGE12F, MAGE12F antigen, MAGEA12, Melanoma antigen family A 12, Melanoma associated antigen 12, Melanoma-associated antigen 12.
Background: Not known, though may play a role in tumor transformation or aspects of tumor progression.Tissue specificity: Expressed in many tumors of several types, such as melanoma, head and neck squamous cell carcinoma, lung carcinoma and breast carcinoma, but not in normal tissues except for testes.
-
ID gène
- 4111
Antigène
-